MétaCan
Menu
Retour à la cohorte
Enregistrement W4401972889 · doi:10.1093/pch/pxae049

Precision of point of care glucose metre measurements in the context of neonatal hypoglycemia

2024· article· en· W4401972889 sur OpenAlexaffabout
Julie Shaw, Saranya Arnoldo, Sukhbir Kaur, Michael J. Knauer, Felix Leung, Heather A. Paul, Vinita Thakur, Davor Brinc

Notice bibliographique

RevuePaediatrics & Child Health · 2024
Typearticle
Langueen
DomaineMedicine
ThématiqueHyperglycemia and glycemic control in critically ill and hospitalized patients
Établissements canadiensMemorial University of NewfoundlandCalgary Laboratory ServicesSinai Health SystemLondon Health Sciences CentreUniversity of TorontoWestern UniversityUniversity of CalgarySaskatchewan Health AuthorityTrillium Health CentreCanadian Electricity AssociationSaskatchewan HealthUniversity of OttawaUniversity Health NetworkOttawa Hospital
Organismes subventionnairesnon disponible
Mots-clésGlucose meterHypoglycemiaContext (archaeology)Neonatal hypoglycemiaMetrePoint (geometry)Point of careMedicineEndocrinologyMathematicsDiabetes mellitusPhysicsHistoryBiologyNursingPregnancy

Résumé

récupéré en direct d'OpenAlex

Point of care testing (POCT) for capillary blood glucose is commonly used in the neonatal population (<28 days old) to guide hypoglycemia treatment. The Canadian Pediatric Society recommends treatment of hypoglycemia in neonatal patients when the blood glucose concentration is (i) <2.6 mmol/L in the first 72 h or (ii) <3.3 mmol/L after 72 h of life (1). The accuracy of laboratory measurements is dependent on the method’s bias and precision. Bias refers to the closeness of a measured value to the true value. Our previous study demonstrated the expected bias for POCT glucose measurements compared to central laboratory measurements for two hospital-approved devices. The Roche Inform II metre showed a positive bias of approximately 0.3 mmol/L and the Nova StatStrip showed a negative bias of approximately 0.4 mmol/L compared to the central laboratory for glucose measurements <3.0 mmol/L (2). Here, we present follow-up data, illustrating the imprecision of POCT glucose metres based on real clinical repeat measurements. Precision is the ability to replicate the same result with repeat measurements of the same sample and is typically expressed as the coefficient of variation (CV), which is the standard deviation (SD) divided by the mean value, expressed as a percent. Our data demonstrate the expected variability with repeat POCT glucose measurements, which can help clinicians determine if observed differences are clinically significant or due to inherent metre imprecision. Repeat POCT glucose results from neonates were obtained from five hospital sites in Ontario, including The Ottawa Hospital (n = 98), London Health Sciences Centre (n = 100), Trillium Partners (n = 340), William Osler Health (n = 119), and Lakeridge Health (n = 89). All repeat measurements were performed on the same patient within 2 min. Seven hundred and forty-six repeat measurements were identified, from two models of POCT glucose metre, the Nova Stat Strip (n = 548) and the Roche Accuchek Inform II (n = 198). Data were categorized into three bins based on the initial POCT measured glucose concentration (<2.6 mmol/L, 2.6 to 3.3 mmol/L, >3.3 mmol/L). The SD was calculated for each set of repeats along with the CV (SD divided by the mean, expressed as a percentage). The average CV for all repeat measurements was calculated for each concentration bin. Differences between repeat measurements <4.0 mmol/L are shown in Figure 1. The mean CV for repeat glucose measurements between <2.6 mmol/L (n = 390) was 7.4% (95% CI 6.7 to 8.1), for measurements 2.6 to 3.3 mmol/L (n = 297) was 5.5% (CI 4.9 to 6.0) and for measurements >3.3 mmo/L (n = 59) was 3.9% (CI 2.9 to 4.9). Repeat measurements were most often equivalent or higher when the initial measurement was ≤3.3 mmol/L (542/687). No consistent trend was for initial measurements >3.3 mmol/L. Difference plot showing the initial measurement on the x-axis and difference between initial and repeat measurement on type y-axis. Initial measurements <2.6 mmol/L are shown in black, initial measurements 2.6 to 3.3 mmol/L are shown in white with black outline, and initial measurements 3.4 to 4.0 mmol/L are shown in grey. Data for initial measurements >4.0 mmol/L are not included to allow for better visualization of the data for a lower initial concentration range Here, we highlight the imprecision of POCT glucose measurements based on repeat measurements in neonatal patients across two models of metres from five hospital sites. Our previous work demonstrated imprecision of approximately 6% for glucose concentrations around 2.5 mmol/L, based on quality control measurements. Here, the imprecision of repeat measurements with patient samples is similar to what was seen with repeat measurements of quality control material for glucose concentrations 2.6 to 3.3 mmol/L. Our data suggests that when an initial POCT glucose measurement of 2.6 mmol/L is repeated within 2 min of the first measurement, the repeat measurement could be anywhere from 2.5 to 2.7 mmol/L, based on one SD. A repeat of an initial measurement of 3.3 mmol/L within 2 min could yield a result between 3.1 and 3.5 mmol/L, based on one SD. Thus, when repeat POCT measurements are made, a repeat glucose measurement different from the initial glucose measurement may not represent a true difference if the result is within two SDs (11%) based on expected imprecision. The Canadian Standards Association recommends imprecision of no more than 12.5% and 7.5% for glucose <2.5 mmol/L and ≥2.5 mmol/L, respectively, for diabetes management (3). It is important for clinicians to interpret repeat measurement values in the context of expected differences based on inherent imprecision. Some limitations of our study relate to not knowing what occurred between the initial and repeat measurements. Was the repeat measurement made using a fresh capillary specimen? Did treatment occur between repeats? Lastly, the reason for performing a repeat measurement is unknown. It is possible the repeat measurement was initiated due to an error associated with the first measurement. In summary, we recommend that physicians caring for neonatal patients consider the following: Understanding glucose metre precision and bias and discussing this with the local laboratory. Keeping in mind the inherent imprecision of POCT metres when interpreting repeat measurements to help determine whether a change is real. Sending specimens to the laboratory for confirmatory measurements or when POCT results do not fit clinically, rather than ordering repeat POCT measurements. No funding to report. All authors: All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. J. Shaw and M. Knauer have received in-kind POCT devices and reagents from Roche Diagnostics for research studies.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,031
score de la tête « metaresearch » (Gemma)0,081
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,031
Score d'incertitude au seuil0,163

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0310,081
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0020,002
Études des sciences et des technologies0,0010,001
Communication savante0,0040,001
Science ouverte0,0020,002
Intégrité de la recherche0,0020,002
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,019
Tête enseignante GPT0,301
Écart entre enseignants0,282 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations2
Publié2024
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revuePaediatrics & Child HealthMême sujetHyperglycemia and glycemic control in critically ill and hospitalized patientsTravaux en français237 207